User–producer interactions in functional genomics innovations
Ellen Moors
Copernicus Institute for Sustainable Development and Innovation, Utrecht University, The Netherlands
Christien Enzing
TNO Strategy, Technology and Policy, Delft, The Netherlands
Annelieke van der Giessen
TNO Strategy, Technology and Policy, Delft, The Netherlands
Ruud Smits
Copernicus Institute for Sustainable Development and Innovation, Utrecht University, The Netherlands
PP: 120
Abstract
Now we are at the doorstep of the functional genomics era, lessons can be learned from the debates on risks, public acceptance and ethical aspects of biotechnology, by anticipating on users' preferences and needs, and by involving users in the innovation process. Insights into the user-producer interactions are also important because developments in nutrigenomics and pharmacogenomics may cause a shift towards an individualised consumer demand and a de-fragmented market.
The relation between users and producers will alter when the genomics 'products' become customised (eg tailor-made drugs, functional foods). In order to get a better understanding of the interaction between users and producers in functional genomics innovations and to learn about a useful participation of users in genomics developments, this exploratory paper focuses on what we can learn from innovation studies about the role of users in functional genomics innovations. This leads to recommendations for governance of biotechnology in general and functional genomics in particular.
Keywords
biotechnology, ethics, nutrigenomics, pharmacogenomics, public acceptance, individualised demand, customised products, governance
References
Akrich M (1992) The De-Scription of Technical Objects, in Bijker WE and Law J (eds) Shaping Technology/Building Society: Studies in Sociotechnical Change, London: MIT Press, pp.205-224.
-- (1995) User representations: practices, methods and sociology, in Rip A, Misa TJ and Schot J (eds) Managing Technology in Society: The approach of constructive technology assessment, London/New York: Pinter Publishers, pp.167-184.
Bolt LLE, van Delden JJM, Derijks HJ, Kalis A and Leufkens HGM (2002) Tailor-made pharmacy: Future developments and ethical challenges in the field of pharmacogenomics, essay for the NWO programme on the Societal Component of Genomics, Utrecht University.
Bijker WE (1995) On Bikes, Bicycles and Bakelite. Cambridge MA: MIT Press.
Bijman JW and Enzing CM (1995) Biotechnology and vertical coordination in the agrofood chain: A Case study of the Dutch Potato Chain, in Science and Public Policy 22(6): 391-398.
Brom FWA, Cohen N, Waelbers K and van Zutphen LFM (2002) Towards an integrated network on Genomics and Society in the Netherlands, essay for the NWO programme on the Societal Component of Genomics, Utrecht University.
Duyndam A (2002) Leeg. Redactioneel 27 juli, Chemisch Weekblad 15: 3.
Chen Z and McDermott A (1998) International comparisons of biotechnology policies, Journal of Consumer Policy 21: 527-550.
Commission of European Communities (2001) Towards a strategic vision of life sciences and biotechnology, consultation document, EU, Brussels.
Coombs R, Green K, Richards A and Walsh V (eds) (2001) Technology and the Market. Demand, Users and Innovation. Cheltenham and Northampton: Edward Elgar.
Cowan RS (1987) The Consumption Junction: A Proposal for Research Strategies in the Sociology of Technology, in Bijker WE, Hughes TP and Pinch TJ (eds) The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology. Cambridge: MIT Press, pp.261-280.
Enzing CM (1995) Overzicht van wetgeving, maatregelen en activiteiten betreffende biotechnologie activiteiten van bedrijven, Achtergrondstudie in opdracht van het Rathenau Instituut, TNO-STB, Apeldoorn.
Enzing CM (2000) Dossier Biotechnologie. Bijlage 2 bij de: Integrale Nota Biotechnologie van de ministers van EZ, OCW, LNV, VWS en VROM, Den Haag, ook verschenen als TNO-rapport STB-00-52.
Enzing CM and Sterrenberg L (1988) Eenzijdig beleid: Pleidooi voor een integraal (bio)technologie beleid (Unidirectional Policy: Plea for an integral (bio)technology policy), in Intermediair 24(25).
Enzing CM and van der Giessen AM (2002) Voedingsgenomicsonderzoek: ontwikkelingen en maatschappelijke impact, TNO-STB, studie voor Rathenau Instituut, Juni 2002.
Everdingen van JJE, Cohen AF and Feenstra GT (eds) (1999) Ziekten maken en breken. Over farmacogenomie. Amsterdam: Boom/Belvédere.
Featherstone M (1991) Consumer Culture and Postmodernism, London: Sage Publications.
Gezondheidsraad (2000) Farmacogenetica, Den Haag, 2000, Publication No 2000/19.
Habermeyer KF (1990) Product use and product improvement, Research Policy 19: 271-283.
Hanssen L, Gutteling JM, Lagerwerf L, Bartels J and Roeterdink W (2001) In de marge van het publiek debat Eten en Genen. Flankerend onderzoek in opdracht van de Commissie Biotechnologie en Voedsel. Aspect 69. Enschede: Universiteit Twente.
Hanssen L, van Est R and Enzing C (2002) Het participatieve gen. Participatieve instrumenten in het omgaan met maatschappelijke vraagstukken over ontwikkelingen in voedingsgenomics, Esay geschreven in het kader van het NWO programma 'Maatschappelijke Component Genomics'. Nijmegen/Den Haag/Delft.
Herstatt C and von Hippel E (1992) Developing New Product Concepts via the Lead User Methods: A Case Study in Low-Tech Field, Journal of Product Innovation Management 9: 213-221.
Hoogma R (2000) Exploiting Technological Niches. Thesis, Enschede: Twente University Press.
Hoogma R and Schot JW (2001) How innovative are users? A critique of learning-by-doing and -using, in Coombs R, Green K, Richards A and Walsh V (eds) Technology and the Market. Demands, Users and Innovation, Edward Elgar, pp.216-233.
Howells J (2000) Innovation & Services: New Conceptual Frameworks, CRIC Discussion Paper No 38, CRIC, The University of Manchester & UMIST, pp.1-29.
INRA (Europe) - ECOSA (2000) The Europeans and biotechnology - Eurobarometer 52.1, Report for the Research Directorate-General and the Education and Culture Directorate-General, http://europa.eu.int/comm/research/pdf/eurobarometer-en.pdf.
Kemp R, Schot J and Hoogma R (1998) Regime Shifts to Sustainability Through Processes of Niche Formation, Technology Analysis & Strategic Management 10(2): 175-195.
Kern S and Enzing CM (2002) The Dutch Biotechnology Innovation System: An inventory and assessment of the major developments since 1994, TNO-STB, January.
Lang J and Wood SC (1999) Development of orphan vaccines: an industry perspective, Emerging Infectious Diseases 5: 749-757.
Leufkens HGM (2001) De betekenis van 'genomics' voor de toekomst van de farmacotherapie, in Timmerman H et al (eds) Geneesmiddelen nu en in de toekomst: Volksgezondheid Toekomst Verkenning 2002, Houten, RIVM, Bilthoven, pp.491-504.
Leonard-Barton D (1988) Implementation as a Mutual Adaptation of Technology and Organisation, Research Policy 17: 251-267.
Lundvall BA (1988) Innovation as an Interactive Process: From User-Producer Interaction to the National System of Innovation, in Dosi G, Freeman C, Nelson R et al (eds) Technical Change and Economic Theory, London: Pinter, pp.349-369.
-- (1992) National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning. London: Pinter Publishers.
Massoud M, Ragozin H and Schmid G (2001) The Future of Nutrition: Consumers Engage with Science, Institute for the Future New Consumer, New Genetics Programme.
Maussen LJ (2001) Economic Evaluation of Pharmacogenomics, Scriptie Universiteit Utrecht, Faculteit Farmacie.
Michaut AMK, Van Trijp HCM and Steenkamp JEM (2000) ‘What's new? A multi-dimensional approach to product newness', Work in Progress for the Mansholt Multidisciplinary Seminar, 20 December 2000.
Moors EHM, Faber J, Hekkert M and Meeus M (2002a) 'Innovation Systems Barriers in Orphan Drugs Development in the Netherlands. An Exploratory Analysis', paper GIN Conference, Gothenborg, June 2002.
Moors EHM and Smits REHM (2002b) ‘Innovations in the biotech industry: Threats and challenges', Paper for 9th Netherlands Biotechnology Congress, March 14-15 2002, Ede, The Netherlands.
NIABA (2001) Brief aan Commissie Terlouw over bijdrage NIABA aan debat Eten en Genen, 21 december 2001.
Nefarma (2002) Annual Report 2001.
Nelson RR and Winter SG (1982) An evolutionary theory of economic change, Belknap Press.
Oudshoorn N and Pinch TJ (eds) (2003) How Users Matter. The co-construction of users and technologies, forthcoming at MIT Press.
Phost DR, Boyle-Jacino MT and Grant DM (2000) A SNPshot: pharmacogenetics and the future of drug therapy, Trends in Biotechnology 18: 334-338.
Pinch TJ and Bijker WE (1984) The Social Construction of Facts and Artefacts: Or How the Sociology of Science and the Sociology of Technology Might Benefit Each Other, Social Studies of Science 14: 399-431.
Raad voor Gezondheidsonderzoek RGO (1998) Advies Orphan Drugs (weesgeneesmiddelen), advies 16, Rijswijk.
Raad voor Landelijk Gebied (2001) Agribusiness: steeds meer business, steeds minder agri, advies over de vestigingsvoorwaarden voor internationale agribusiness.
Rogers EM (1971) Communication of Innovations. A Cross-Cultural Approach, London: The Free Press.
Rosenberg N (1976) Perspectives on Technology, Cambridge MA: Cambridge University press.
-- (1982) Inside the Black Box: Technology and Economics, Cambridge MA: Cambridge University Press.
Sabatier PA (1987) Knowledge, Policy-Oriented Learning and Policy Change. And Advocacy Coalitions Framework, Knowledge 8: 17-50.
Schellekens H, van Bragt PH, Olijve W and van der Weele CN (2001) Medische Biotechnologie, Maarssen: Elsevier Gezondheidszorg.
Schot J (2001) Towards New Forms of Participatory Technology Development, Technology Analysis & Strategic Management, vol. 13, no. 1, pp.39-52.
Schot J and De La Bruheze AA (2002) The Mediated Design of Products, Consumption and Consumers in the Twentieth Century, in Oudshoorn N and Pinch TJ (eds) How Users Matter: The Co-Construction of Users and Technology, forthcoming at MIT Press.
Schumpeter JA (1934), The Theory of Economic Development, Cambridge, Massachusetts.
-- (1943) Capitalism, Socialism & Democracy, Allen & Unwin, London, 5th edn 1976.
Sciona (2002) www.sciona.com.
Silverstone R and Hirsch E (1992) Consuming technologies: media and information in domestic spaces, London: Routledge.
Silverstone R and Haddon L (1996) Design and the Domestication of Information and Communication Technologies: Technical Changes in Everyday Life, in Mansell R and Silverstone R (eds) Communication by Design: The Politics of Information and Communication Technologies, Oxford/New York: Oxford University Press, pp.47-77.
Slaughter S (1993) Innovation and learning during implementation: a comparison of user and manufacturer innovations, Research Policy 22: 81-95.
Smits R, Leyten A and den Hertog P (1995) Technology Assessment and technology policy in Europe: new concepts, new goals, new infrastructures, Policy Sciences 28: 272-299.
Smits R (2002) Innovation Studies in the 21st Century: Questions from a user's perspective, Technological Forecasting and Social Change, forthcoming.
Smits R and Kuhlmann S (2002) ‘Strengthening Interfaces in Innovation Systems: rationale, concepts and (new) instruments', report prepared for EC STRATA Workshop, Brussels, 22-23 April 2002.
Stichting Merkartikel SMA (2002) SMA Jaarbericht 2001.
Stroeken J (2001) Het waarom van succes of falen, EYE innovatiespecial, januari.
Van Lente H, Hekkert M, Smits R and van Waveren B (2002) ‘Roles of Strategic Intermediaries in Transition Processes: The Case of Energy Innovation Systems', paper presented at the Workshop 'Transitions to Sustainability through Systems Innovations', University of Twente, 4-6 July 2002.
Von Hippel E (1976) The dominant role of users in the scientific instrument innovation process, Research Policy 5: 212-239.
-- (1986) Lead Users: A Source of Novel Product Concepts, Management Science 32(7): 791-805.
-- (1988) The Sources of Innovation, Oxford: Oxford University Press.
Von Hippel E and Tyre M (1995) How Learning by Doing is Done: Problem Identification in Novel Process Equipment, Research Policy 24: 1-12.
Von Hippel E (2001) Perspective: User toolkits for innovation, Journal of Product Innovation Management 18(4): 247-257.
Waarlo AJ et al (2002) Competence-oriented genomics and education, essay for the NWO Programme on the Societal Component of Genomics, Utrecht University.
Walsh V (1993) Demand, Public Markets and Innovation in Biotechnology, SPP Science and Public Policy 20(3): 138-156.
Woolgar S (1991) Configuring the User: The Case of Usability Trials, in Law J (ed) A Sociology of Monsters: Essays on Power, Technology and Domination, London: Routledge.
BioFarmInd: www.biofarmind.nl
Nefarma: www.nefarma.nl
Sciona: www.sciona.com
eContent Home
